I agree that on-patent brand name drugs are the real money maker for these companies but I don’t see why there wouldn’t be a market for a manufacturer to jump in and standardize the dossage/side effects of a maraijuna based medication. Sure someone could sell a strain with similar effects but that is the nature of…